ClinicalTrials.govpublic full text
SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma
hepatocellular carcinoma, sbrt, immune checkpoint blockade, tyrosine kinase inhibitor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1047748
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.